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Abstract The new antigen receptor (NAR) from sharks consists
of a single immunoglobulin variable domain attached to five
constant domains, and is hypothesised to function as an antibody.
Two closely related NARs with affinity for the Kgp (lysine-
specific) gingipain protease from Porphyromonas gingivalis were
selected by panning an NAR variable domain library. When
produced in Escherichia coli, these recombinant NARs were
stable, correctly folded, and specifically bound Kgp
(Kd = 1.31 þ 0.26U1037 M). Binding localised to the Kgp
adhesin domains, however without inhibiting adhesin activity.
These naturally occurring proteins indicate an immune response
to pathogenic bacteria and suggest that the NAR is a true
antibody-like molecule. ß 2002 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The immune systems of cartilaginous ¢sh employ a diverse
range of antibody and antibody-like proteins, including
monomeric and pentameric IgM, IgX, and IgW [1,2]. These
proteins are all of conventional antibody architecture, relying
on the interaction of heavy (VH) and light (VL) domains to
form an antigen-binding site comprising four to six variable
CDR loops. In contrast, the new antigen receptors (NARs)
from Ginglymostoma cirratum (nurse sharks, nNAR) and
Orectolobus maculatus (wobbegong sharks, wNAR) encapsu-
late variability within two CDR loops of a single VH domain.
It is clear from immune electron microscopy that there is no
associated light chain and that the variable domains do not
associate together across a VH/VL-like interface [3]. Structur-
ally, the intact NAR molecule consists of a disulphide-bonded
dimer of two protein chains of ¢ve constant and one variable
immunoglobulin domains. This arrangement, and particularly
the single variable domain, is very similar to the VHH anti-
bodies found in camelid species in a clear case of convergent
evolution at the molecular level [3,4]. VHHs are capable of
binding a wide range of protein, hapten and peptide targets
and represent a signi¢cant proportion of the camelid immune
response [5,6]. While a similar function for the NAR in the
shark immune response awaits formal proof, there is strong
evidence that NARs are functional antibodies. For example,
NARs show (i) protein variability that is almost exclusively
encapsulated into the two major CDR loop regions, with
maintenance of a conserved underlying immunoglobulin
structural framework; and (ii) a pattern of hypermutation in
the CDRs between secretory and transmembrane forms, anal-
ogous to the process of a⁄nity maturation in mammalian IgG
class molecules [7,8].
In a previous study, we showed that the individual wNAR
variable domains could be expressed as soluble monomers in
the Escherichia coli periplasm. An in vitro type II wNAR
library was then designed with synthetic CDR3 loops, and
successfully displayed on the surface of fd bacteriophages.
Library panning using standard techniques against target pro-
teins resulted in the isolation of NAR domains speci¢c for
proteins from Porphyromonas gingivalis [9]. P. gingivalis is
an anaerobic bacterium strongly associated with human pe-
riodontal disease where virulence is mediated through a range
of extracellular factors including the related gingipain cysteine
proteases Kgp (speci¢c for lysine residues) and HRgp (speci¢c
for arginine residues) [10]. Both proteases are high molecular
weight complexes of a gingipain catalytic domain and have up
to four haemagglutinin/adhesion subunits.
Here we report the results of further screening of NAR
single variable domain libraries against Kgp, using an ex-
panded library and screening techniques di¡erent to those
previously reported. Surprisingly, we observed strong selec-
tion for two naturally occurring NAR proteins not derived
from our synthetic CDR3 library. In this ¢rst description of
antigen speci¢city in natural NARs, we analyse the binding
characteristics of these antibody-like domains.
2. Material and methods
2.1. Equipment and reagents
Vent DNA polymerase and all restriction enzymes were purchased
from New England Biolabs (Beverley, MA, USA) and used according
to the manufacturer’s instructions. T4 DNA ligase was from Biotech
(Australia). DNA fragment recovery and puri¢cation was by QIA-
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quick Gel Extraction Kit, Qiagen (Germany). Small-scale prepara-
tions of DNA from E. coli were by QIAprep Spin Miniprep kit,
Qiagen (Germany). Monoclonal anti-FLAG antibody was puri¢ed
from hybridoma cell line KM5-1C7-8-5 (provided by Dr. N. Nicola,
CRC for Cellular Growth Factors, WEHI, Australia) using rProtein
A Sepharose fast £ow resin from Amersham Pharmacia Biotech (Aus-
tralia) according to the manufacturer’s instructions. Puri¢ed anti-
FLAG antibody was immobilised onto Mini-Leak1 Low resin from
Kem-En-Tec (Denmark) following the manufacturer’s instructions, to
generate anti-FLAG a⁄nity resin. Goat anti-mouse IgG (Fc)-horse-
radish peroxidase (HRP) was from Pierce. BenchMark1 Prestained
Protein Ladder Cat. # 10748-010 was from Gibco BRL Life Tech-
nologies (Gaithersburg, MA, USA). Standard molecular biological
techniques were performed as described [11]. HRgpA, RgpB and
Kgp were puri¢ed from the H66 strain culture £uid as described
previously [12].
2.2. E. coli strains
The cell line used for library propagation and selection and protein
expression was E. coli TG1 (K12 supE v(lac-proAB) thi hsdv5
FP{traD36 proAB lacIq lacZvM15}. E. coli transformants were
maintained and grown in 2UYT broth supplemented with 100 Wg/
ml (w/v) ampicillin +/3 2% (w/v) glucose. Solid media contained
2% (w/v) Bacto-agar. Transformation of E. coli was by standard pro-
cedures [11] performed using electro-competent cells.
2.3. Library construction and panning
DNA library cassettes encoding the wNAR were constructed from
cDNA as described [9]. The total library size was V4.0U108 inde-
pendent clones, consisting of s 3U108 clones with synthetic CDR3
sequences, and V7.0U106 clones derived from natural cDNAs. Li-
brary contributions were normalised in proportion to their sizes prior
to panning, and phagemid particles carrying the NAR-gene 3 protein
were propagated and isolated by standard procedures [13]. For bio-
panning of the phagemid library, Kgp (2 Wg/ml in phosphate-bu¡ered
saline (PBS)) was coated onto Maxisorb Immunotubes and incubated
at 4‡C overnight. Immunotubes were rinsed (PBS), blocked with PBS/
2% Blotto for 1 h at room temperature (RT), and incubated with
freshly prepared phagemid particles (in PBS/2% Blotto) for 30 min
at RT with gentle agitation, followed by 90 min without agitation.
After incubation, immunotubes were washed (PBS/0.1% Tween 20; 7,
8, 10 washes for panning rounds 1^3), followed by an identical set of
washes with PBS. Phagemid particles were eluted using 0.1 M HCl,
pH 2.2/1 mg/ml bovine serum albumin, neutralised by the addition of
2 M Tris base, and either immediately reinfected into E. coli TG1 or
stored at 4‡C.
2.4. Nucleic acid isolation and cloning
Following ¢nal selection, phagemid particles were infected into E.
coli TG1 and propagated as plasmids, followed by DNA extraction.
The NAR cassette was extracted as a Not1/S¢1 fragment and sub-
cloned into the similarly restricted cloning/expression vector pGC [14].
DNA clones were sequenced on both strands using a BigDye termi-
nator cycle sequencing kit (Applied Biosystems, USA) and a Perkin
Elmer Sequenator. The nucleotide sequence of clones 12A-9 and 12A-
14 associated with this study are deposited in the GenBank database
under accession numbers AF466395 and AF466396.
2.5. Soluble expression of wNAR constructs from expression vector
pGC
Recombinant proteins were expressed in the bacterial periplasm as
described [9]. Brie£y, E. coli TG1 starter cultures were grown over-
night in 2UYT medium/ampicillin (100 Wg/ml)/ glucose (2.0% w/v),
diluted 1/100 into fresh 2UYT/100 Wg/ml ampicillin/glucose (0.1% w/
v) and then grown at 37‡C/200 rpm until OD550 nm = 0.2^0.4. Cultures
were then induced with IPTG (1 mM ¢nal), grown for a further 16 h
at 28‡C and harvested by centrifugation (Beckman JA-14/6K/10 min/
4‡C). Periplasmic fractions were isolated by the method of Minsky
[15] and either used as crude fractions or recombinant protein puri¢ed
by a⁄nity chromatography using an anti-FLAG antibody^Sepharose
column (10U1 cm). The a⁄nity column was equilibrated in PBS, pH
7.4, and bound protein eluted with ImmunoPure1 gentle elution bu¡-
er (Pierce). Eluted proteins were dialysed against two changes of PBS/
0.02% sodium azide, concentrated by ultra¢ltration over a 3000 Da
cuto¡ membrane (YM3, Dia£o), and analysed by FPLC on a pre-
calibrated Superdex75 column (Pharmacia) in PBS pH 7.4. Recombi-
nant proteins were analysed by SDS^polyacrylamide gel electropho-
resis through 15% Tris/glycine gels.
2.6. Enzyme-linked immunosorbent assays
Protein antigens (0.5 Wg/well) in PBS were coated onto Maxisorb
Immuno-plates (Nunc, Germany) and incubated at 4‡C overnight.
Plates were rinsed, blocked with PBS/5% Blotto for 1 h at RT, and
incubated with periplasmic fractions or recombinant protein for 1 h at
RT. Plates were rinsed with PBS, washed three times with PBS/0.05%
Tween 20, and anti-FLAG antibody (1/1000 in PBS/5% Blotto)
added. Plates were incubated and washed as above, and the HRP-
conjugated secondary anti-mouse Fc antibody added (1/1000 in PBS/
5% Blotto). Plates were washed again and developed using 2,2-azino-
di-(ethyl) benzothiazoline sulphonic acid (Boehringer Mannheim, Ger-
many) and read at OD405 nm.
For localisation of Kgp binding, ¢brinogen (10 nM) in PBS was
coated as above, and the plates then rinsed, blocked with PBS/1%
Blotto for 1 h at 37‡C, and washed three times with PBS/0.1% Tween
20. Plates were then incubated with either 30 nM of gingipain alone or
gingipain+3 WM 12A-9 for 1 h at 37‡C, washed as above, and incu-
bated with 10 Wg/ml chicken anti-gingipain antibody for 1 h at 37‡C
before addition of a HRP-conjugated anti-chicken antibody (1/10000
in PBS/1%Blotto). Plates were washed again and developed using
3,3P,5,5P-tetramethylbenzidine (Sigma, USA) and read at 450 nm.
2.7. Biosensor binding analysis
A BIAcore1 1000 biosensor (BIAcore AB, Uppsala, Sweden) was
used to measure the interaction between wNAR proteins 12A-9 and
12A-14, and Kgp. Kgp at a concentration of 50 Wg/ml in 10 mM
sodium acetate bu¡er, pH 4.5, was immobilised onto a CM5 sensor
chip via amine groups using the Amine Coupling kit (BIAcore AB)
[16]. The immobilisation was performed at 25‡C and 5 Wl/min £ow
rate. Injection of 50 Wl of 50 Wg/ml Kgp coupled 2000RU to the
surface. Binding experiments were performed in HBS bu¡er (10 mM
HEPES, 0.15 M NaCl, 1 mM CaCl2, 0.005% surfactant P20, pH 8.15)
at 25‡C and a constant £ow rate of 5 Wl/min with a series of analyte
concentrations (825^52.5 nM). Regeneration of the Kgp surface was
achieved by running the dissociation reaction to completion before the
next injection of analyte. The binding data was evaluated with BIA-
evaluation 3.0.2 [17].
3. Results
3.1. Panning of an expanded wNAR variable domain library on
Kgp
Previously we described the design and construction of a
wNAR variable domain library with synthetic CDR3 loops.
This library, although small (V3U107), was successfully dis-
played on the surface of fd bacteriophage and panned against
Kgp displayed in the context of ELISA plate wells [9]. In
order to isolate further antigen-speci¢c NAR domains, the
library was expanded to V4U108 independent clones by in-
corporation of both synthetic and naturally occurring (derived
from cDNA) CDR3 sequences, followed by further transfor-
mations into E. coli TG1. Phagemid particles were then res-
cued and panned against the Kgp antigen immobilised on
immunotubes. After three rounds of biopanning an V100-
fold increase in bacteriophage titre was observed, with 100%
of phagemid-transfected colonies positive for wNAR sequen-
ces suggesting that positive selection was occurring. Thus,
wNAR variable domain cassettes were rescued from phage-
mids, cloned into the periplasmic expression vector pGC, and
transformed into E. coli TG1.
Periplasmic fractions from recombinant clones were tested
for binding to Kgp and to negative control antigens by ELI-
SA (not shown). Over 50% of the clones tested showed sig-
ni¢cant binding above background. When sequenced, only
two di¡erent sequences were present, represented by the
clones designated 12A-9 and 12A-14. The primary and de-
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duced amino acid sequences of 12A-9 and 12A-14 are pre-
sented in Fig. 1A. Both proteins represent 108 residue
wNAR variable domains and are obviously closely related
(Fig. 1B), with di¡erences distributed evenly between frame-
work and loop regions (particularly CDR3). Surprisingly, the
CDR3 loops are both only 13 residues in length, compared to
15^18 incorporated in the in vitro CDR3 library. Similarly,
framework residue 84, which was conserved as either a gluta-
mine or alanine in the synthetic library, encoded a lysine res-
idue in both proteins (Fig. 1B). This indicates that proteins
12A-9 and 12A-14 are naturally selected domains, as it is
highly unlikely that two antigen-speci¢c clones could have
been independently mutated in the arti¢cial library to the
same size CDR3, both containing Lys84 and with other di¡er-
Fig. 1. Nucleotide and deduced amino acid sequences of the wNAR 12A-9 and 12A-14 variable domains. A: Nucleotide and deduced amino
acid sequences of clones 12A-9 and 12A-14. The conserved termini dictated by the oligonucleotide primer sequences used in library construction
are underlined, and the alanine linker and dual octapeptide FLAG tags are italicised. The positions of the CDR1 and -3 regions are indicated
in bold type. B: Alignment of proteins 12A-9 and 12A-14. Amino acids are designated with the single-letter code, and identical residues (dark
shading) and conservative replacements (light shading; I/V/L/M, D/E, K/R, A/G, T/S, Q/N, F/Y) are indicated. The framework residue Lys84,
which indicates that these are naturally occurring NARs, is arrowed, and the CDR1 and -3 regions are indicated.
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ences scattered throughout both CDR and framework regions
(Fig. 1B). It is notable that conserved cysteine residues are
present in both CDR1 and -3 loops, and probably form sta-
bilising inter-loop disulphide linkages [3,6,9].
3.2. Characterisation of recombinant 12A-9 and 12A-14
variable domains
To compare proteins 12A-9 and 12A-14 and to de¢ne their
binding characteristics, recombinant proteins were isolated
from the E. coli periplasm by a⁄nity chromatography using
an anti-FLAG antibody a⁄nity resin and their oligomeric
status analysed by size exclusion chromatography on a cali-
brated Superdex75 HR10/30 column. The elution pro¢les
showed that both proteins contained two major oligomeric
forms (Fig. 2A). The elution times indicated that 12A-14 con-
sisted of a monomer (MrV14 kDa) and a dimer (MrV28
kDa), while 12A-9 consisted of a monomer and a trimer
(V42 kDa) (Fig. 2A, inset). The presence of a dimer and
trimer in a⁄nity-puri¢ed fractions of 12A-14 and 12A-9, re-
spectively, was con¢rmed by dynamic light scattering analysis
(data not shown). As clone 12A-9 showed higher expression
levels than clone 12A-14 (1 mg/l compared to 0.2 mg/l puri¢ed
protein) and showed apparently higher binding activity (see
next section), protein 12A-9 was chosen for further analysis.
The monomeric and trimeric peaks of 12A-9 were isolated
by size exclusion chromatography and found to be stable with
no evidence of re-equilibration (Fig. 2B). Furthermore, treat-
ment of 12A-9 trimer in 8 M urea followed by size exclusion
chromatography into PBS yielded back only trimer. The
stability of the trimer was not due to disul¢de bond linkages,
as treatment of 12A-9 trimer with SDS in the absence of
reducing agent produced a single protein band of V14
kDa, expected for the monomer (Fig. 2B, inset). N-terminal
amino acid sequencing of a⁄nity-puri¢ed 12A-9 monomer/
trimer mixture showed that only one protein species was
present with the expected N-terminus (1ARVDQTP^; Fig.
1A) indicating that the signal peptide had been correctly
cleaved on secretion into the E. coli periplasm. Far ultraviolet
CD spectra of aqueous solutions of protein 12A-9 trimer
showed a pro¢le with a negative band with Vmax at 217^219
nm (Fig. 2C). This spectrum is characteristic of L protein and
not a disordered structure [18], con¢rming that the 12A-9
variable domain folds into a compact, L-sheet immunoglobu-
lin fold in the E. coli periplasmic space.
3.3. Speci¢city and binding activity of recombinant protein
12A-9
The speci¢city of a⁄nity-puri¢ed 12A-9 and 12A-14 pro-
teins for Kgp was demonstrated by ELISA. Both proteins
reacted speci¢cally with Kgp but not the other antigens tested
(Fig. 3A). Protein 12A-9 showed clearly superior binding
characteristics with at least ¢ve-fold higher activity than pro-
tein 12A-14 (Fig. 3B). The binding kinetics of the monomeric
12A-9 and 12A-14 were also measured by BIAcore biosensor
analysis with Kgp protein immobilised via amine coupling to
the sensor surface. A comparison of the binding interactions
of 12A-9 and 12A-14 binding to immobilised Kgp showed
that V10 times more 12A-14 was required to elicit a response
similar to that obtained with 12A-9 (Fig. 4A), consistent with
the result observed in the ELISA reaction. The apparent lower
binding activity of 12A-14 can be attributed to either weaker
binding (slow association rate and fast dissociation rate con-
Fig. 2. Size exclusion chromatography and CD analysis of proteins
12A-9 and 12A-14. A: Elution pro¢les of a⁄nity-puri¢ed 12A-9
and 12A-14 proteins on a calibrated Superdex75 HR10/30 column
equilibrated in PBS, pH 7.4, and run at a £ow rate of 0.5 ml/min.
The 12A-14 and 12A-9 peaks eluting at 27 min are consistent with
a monomeric domain (calculated Mr of 14 225 for 12A-14 and
14 122 for 12A-9). The 12A-14 peak eluting at 25 min is consistent
with a dimer (Mr = 28 kDa) and the 12A-9 peak eluting at 23 min
is consistent with a trimer (Mr = 42 kDa). The inset shows the rela-
tionship between molecular mass and elution time for this family of
wNAR domains. The optical density at 214 nm is given in arbitrary
units. B: Re-chromatography of isolated 12A-9 monomer and
trimer peaks on Superdex75 column under the same conditions as
for (A). The inset shows the wNAR 12A-9 trimer treated in the
presence (+) or absence (3) of L-mercaptoethanol and analysed by
SDS^polyacrylamide gel electrophoresis through a 15% (w/v) poly-
acrylamide Tris/glycine gel and stained with Coomassie brilliant
blue. C: Circular dichroic spectrum of a⁄nity-puri¢ed wNAR 12A-
9 in 0.05 M sodium phosphate bu¡er, pH 7.4. The scatter plot
shows data collected and the unbroken line represents an average of
these data points.
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stants) or that only a small fraction (V5%) of the puri¢ed
12A-14 is active in binding immobilised Kgp. Interestingly, a
comparison of the binding kinetics of a⁄nity-puri¢ed 12A-9,
12A-9 monomer, and 12A-9 trimer, showed no di¡erence in
the dissociation rates between monomer and trimer (data not
shown) suggesting that the 12A-9 trimer does not exhibit
multivalent binding to immobilised Kgp. Whether the appar-
ent inability of wNAR 12A-9 trimer to exhibit multivalent
binding is due to the orientation and accessibility of Kgp
epitope on the sensor surface or to the steric orientation of
the CDRs in the 12A-9 trimer remains to be resolved. Protein
12A-9 showed no binding to a blank surface (activated and
then blocked with ethanolamine) in either its monomeric or
trimeric form, indicating that there is no non-speci¢c interac-
tion with the sensor surface (Fig. 4A, inset; and not shown).
A series of sensorgrams for the binding of 12A-9 peak-pu-
ri¢ed monomer are shown in Fig. 4B. The binding data were
¢tted at each concentration to the 1:1 Langmuir binding mod-
el and the kinetic constants evaluated. The data showed a
reasonably good ¢t to the 1:1 binding model, consistent
with wNAR 12A-9 monomer binding to a single epitope on
Kgp, although some deviation from the binding model is ap-
parent towards the end of the dissociation phase. The binding
data gave a value for the ka of 4.29 þ 0.68U104 M31 s31 and
kd of 7.81 þ 1.30U1033 s31 to yield a dissociation constant
(Kd) of 1.31 þ 0.26U1037 M.
3.4. Mapping of the Kgp epitope
To determine the Kgp epitope targeted by protein 12A-9,
di¡erent forms of gingipain were tested for binding. Protein
12A-9 bound both Kgp and the related arginine-speci¢c gin-
gipain, HRgpA, but not the lower molecular weight RgpB
form that lacks most adhesin subunits (results not shown).
This suggested that the adhesin domains formed at least
part of the 12A-9 epitope. However, in a series of competition
ELISA experiment, high concentrations of 12A-9 (3 WM,
more than 10-fold above Kd) failed to inhibit binding of
Kgp or HRgpA to immobilised ¢brinogen and other proteins
such a ¢bronectin (Fig. 5; and results not shown). Thus, ei-
ther the 12A-9 epitope is removed from the adhesin regions
involved in agglutination, or single NAR variable domains are
of insu⁄cient size to block the adhesin binding. Similarly,
protein 12A-9 did not a¡ect the enzyme activity of the gingi-
pains, suggesting that it does not target the catalytic site of the
enzymes.
Fig. 3. Analysis of proteins 12A-9 and 12A-14 by ELISA. A: Proteins were puri¢ed from the periplasmic fraction of E. coli TG1 by a⁄nity
chromatography through an anti-FLAG M2 antibody column and tested for binding to lysozyme, Kgp, Tom70, and K-amylase. Results repre-
sent the average of triplicate wells. B: As for (A) except serial two-fold dilutions of equal amounts of 12A-9 and 12A-14 proteins were tested
for binding to Kgp. Results represent the average of duplicate wells.
Fig. 4. Analysis of proteins 12A-9 and 12A-14 by BIAcore. Binding
of wNAR monomeric proteins to immobilised Kgp (2000RU) was
measured at a constant £ow rate of 5 Wl/min with an injection vol-
ume of 35 Wl. Dissociation was continued with HBS bu¡er until the
response returned to the initial value before injecting the next sam-
ple. A: Sensorgrams showing the binding of wNAR monomeric pro-
teins 12A-9 (6 Wg/ml) and 12A-14 (115 Wg/ml). The inset shows the
binding pro¢le of monomeric wNAR protein 12A-9 (6 Wg/ml) to im-
mobilised Kgp and a blank surface (NHS/EDC activated and
blocked with ethanolamine). B: Sensorgrams showing the binding of
a series of concentrations of wNAR 12A-9 protein (825, 413, 210,
105, 52.5 nM; conditions as in A). The circles show the ¢t to the
data obtained on analysis with the 1:1 Langmuir binding model for
the evaluation of the kinetic rate constants.
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4. Discussion
The isolation of two naturally occurring and antigen-spe-
ci¢c NAR variable domains con¢rms the NAR from sharks as
a functional antibody-like molecule. With an a⁄nity for the
target antigen of V130 nM, these single domains have anti-
gen speci¢city comparable to recombinant forms of the camel-
id VHH single domain antibodies, where the a⁄nity varies
between 2 and 300 nM [5,6]. However, NARs encompass
this a⁄nity in two, rather than three CDR loops, as the
CDR2 region is severely truncated [3,9]. The cysteine residues
seen within many NAR (and camelid) CDR loops are con-
served in both proteins 12A-9 and 12A-14, and probably con-
tribute to the antigen-binding a⁄nity by disulphide bond for-
mation and structural stability.
Both the NAR variable domains reported here can be read-
ily produced as recombinant proteins in E. coli. However,
while a signi¢cant proportion of the 12A-9 and 12A-14 pro-
teins are produced in monomeric form, multimers (dimer and
trimer) also occur. Surprisingly, the isolated monomeric and
multimeric species are remarkably stable, with no evidence of
inter-conversion of peak puri¢ed proteins. The relationship
between the 12A-9 monomer and trimer forms requires fur-
ther investigation and may re£ect non-covalent framework
residue interactions peculiar to these proteins, as other NAR
variable domains we have analysed do not show similar multi-
mer formation and stability and are predominantly mono-
meric proteins. As a trimeric architecture is not expected to
occur in native NAR molecules, where the variable domains
are tethered to constant regions, it is possible that their exis-
tence here as trimeric variable domains is an unusual side-
e¡ect of recombinant expression. Ultimately, resolution of
these questions will probably require X-ray crystallographic
data to de¢ne the precise nature of the NAR solvent-exposed
residues and surfaces.
The 12A-9 and 12A-14 NAR domains are clearly derived
from functional shark cDNAs and show no similarity, beyond
invariant regions in the underlying framework, to the anti-
Kgp NARs isolated previously [9]. These earlier proteins
have synthetic rather than naturally selected CDR3 loops
and were not a⁄nity matured. Thus, it is likely that clones
12A-9 and 12A-14, introduced in the expanded library, e⁄-
ciently out-competed any other Kgp-speci¢c proteins. Alter-
natively, it is well documented that di¡erent selection matrices
(immunotubes, this study; versus ELISA plates [9]) can pro-
duce radically di¡erent antibody selection solutions, even
when screening is performed exactly in parallel [19]. The iso-
lation of natural Kgp gingipain-speci¢c NARs in sharks is
perhaps surprising. However, while little is known about the
oral micro£ora of sharks, one study reported isolation of
Vibrio, Staphylococcus, and Pseudomonas species from the
teeth of a great white shark [20]. Therefore, it is possible
that wobbegong sharks carry Porphyromonas species and
have mounted an immune response against the protease vir-
ulence determinants. The isolation of the two di¡erent but
obviously closely related NAR proteins may also indicate
the action of a⁄nity maturation processes on an initial low-
a⁄nity NAR molecule. Indeed, clone 12A-14 could represent
such a low-a⁄nity progenitor, with subsequent ‘maturation’
to the 12A-9 form. If so, then both CDR loops and frame-
work regions are being targeted, in what may be the shark
equivalent of mammalian antibody somatic hypermutation.
With speci¢c NAR binding molecules now isolated from
both synthetic libraries generated using arti¢cial loop sequen-
ces, and from the natural immune repertoire of sharks, it is
clear that recombinant NAR variable domain libraries repre-
sent a valuable source of high-a⁄nity single domain binding
reagents. Future experimentation is clearly required to further
compare their stability and structure with that of other anti-
body fragments, and such work is currently in progress.
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